Akèy › Obèsite › Texas › Pharr
Etid klinik pou Obèsite nan Pharr, TX
10 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Pharr (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Ap rekriteFaz 3
- Texas Valley Clinical Research, Weslaco · 12 mi lwen
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Ap rekriteFaz 3
- Texas Valley Clinical Research, Weslaco · 12 mi lwen
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Ap rekriteFaz 2
- Texas Valley Clinical Research, Weslaco · 12 mi lwen
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Ap rekriteFaz 3
- Texas Valley Clinical Research, Weslaco · 12 mi lwen
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Weslaco · 12 mi lwen
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 3
- AURORA-1 Clinical Site, Weslaco · 12 mi lwen
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Ap rekriteFaz 2
- Texas Valley Clinical Research, Weslaco · 12 mi lwen
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Ap rekriteFaz 2
- Texas Valley Clinical Research, Weslaco · 12 mi lwen
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Ap rekriteFaz 2
- Texas Valley Clinical Research, Weslaco · 12 mi lwen
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Ap rekriteFaz 3
- Great Lakes Research Institute - McAllen Research, Pharr
Etid Obèsite nan lòt vil
- Houston, TX44 etid
- Chicago, IL42 etid
- New York City, NY40 etid
- San Antonio, TX39 etid
- Washington, DC33 etid
- Dallas, TX31 etid
- Orlando, FL29 etid
- Boston, MA28 etid
- Miami, FL27 etid
- Las Vegas, NV27 etid
- Atlanta, GA25 etid
- Jacksonville, FL25 etid
Lòt etid nan Pharr
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.